Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population

被引:21
|
作者
Deirdre A. Collins
Anke Hoskins
Thomas Snelling
Kalpani Senasinghe
Jacinta Bowman
Natalie A. Stemberger
Amanda J. Leach
Deborah Lehmann
机构
[1] Edith Cowan University,School of Medical and Health Sciences
[2] University of Western Australia,Wesfarmers Centre of Vaccines & Infectious Diseases, Telethon Kids Institute
[3] Division of Microbiology & Infectious Diseases,Menzies School of Health Research
[4] PathWest Laboratory Medicine WA,undefined
[5] Charles Darwin University,undefined
关键词
Colonization; Pneumococcal disease; Aboriginal; Vaccination; Australia; PCV13;
D O I
10.1186/s41479-017-0038-x
中图分类号
学科分类号
摘要
引用
下载
收藏
相关论文
共 50 条
  • [21] Seroresponses and safety of 13-valent pneumococcal conjugate vaccination in kidney transplant recipients
    Dendle, Claire
    Stuart, Rhonda L.
    Polkinghorne, Kevan R.
    Balloch, Anne
    Kanellis, John
    Ling, Johnathan
    Kummrow, Megan
    Moore, Chelsea
    Thursky, Karin
    Buttery, Jim
    Mulholland, Kim
    Gan, Poh-Yi
    Holdsworth, Stephen
    Mulley, William R.
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (02)
  • [22] Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children
    Navne, Johan Emdal
    Koch, Anders
    Slotved, Hans-Christian
    Andersson, Mikael
    Melbye, Mads
    Ladefoged, Karin
    Borresen, Malene
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2017, 76 : 1 - 8
  • [23] Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children
    Navne, Johan
    Borresen, Malene
    Slotved, Hans-Christian
    Melbye, Mads
    Ladefoged, Karin
    Koch, Anders
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2016, 75 : 38 - 38
  • [24] Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
    Bryant, Kristina A.
    Block, Stan L.
    Baker, Sherryl A.
    Gruber, William C.
    Scott, Daniel A.
    PEDIATRICS, 2010, 125 (05) : 866 - 875
  • [25] Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
    Esposito, Susanna
    Principi, Nicola
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [26] Bacteremic Pneumococcal Pneumonia And Potential Role Of Pneumococcal 13-Valent Conjugate Vaccine
    Novella Sanchez, L.
    Sanz Herrero, F.
    Fernandez-Fabrellas, E.
    Gimeno Cardona, C.
    Tormo, N.
    Chiner, E.
    Cervera, A.
    Briones, M.
    Aguar, M.
    Lera, R.
    Blanquer, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] Invasive pneumococcal disease after implementation of 13-valent pneumococcal conjugate vaccine
    Kyprianidou, S-A.
    Mejbri, M.
    Tornay, A. A.
    Natterer, J.
    Greub, G.
    Crisinel, P-A.
    Asner, S.
    SWISS MEDICAL WEEKLY, 2014, 144 : 42S - 43S
  • [28] Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
    Nikolova, Kristiana Alexandrova
    Andersson, Mikael
    Slotved, Hans-Christian
    Koch, Anders
    VACCINES, 2021, 9 (10)
  • [29] Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children
    Olarte, Liset
    Barson, William J.
    Barson, Ryan M.
    Lin, Philana Ling
    Romero, Jose R.
    Tan, Tina Q.
    Givner, Laurence B.
    Bradley, John S.
    Hoffman, Jill A.
    Hulten, Kristina G.
    Mason, Edward O.
    Kaplan, Sheldon L.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (05) : 767 - 775
  • [30] Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children
    Chapoutot, A. G.
    Dessein, R.
    Guilluy, O.
    Lagree, M.
    Wallet, F.
    Varon, E.
    Martinot, A.
    Dubos, F.
    EPIDEMIOLOGY AND INFECTION, 2016, 144 (03): : 607 - 611